IceCure Medical Ltd. (NASDAQ: ICCM)

IceCure Medical Ltd. is a commercial stage medical device company that develops and commercializes cryoablation systems using liquid nitrogen to ablate benign and malignant tumors. The company's flagship product is the ProSense system which has received FDA marketing authorization for treating low risk breast cancer in women aged 70 and above who receive adjuvant endocrine therapy. IceCure also offers the IceSense3 and XSense systems and is developing the MSense platform along with disposable probes and introducers that are used with its systems.

IceCure generates revenue primarily from the sale of its cryoablation systems and disposable probes to distributors and end users as well as from service and maintenance contracts for its equipment. The company follows a razor/razor blade model where recurring revenue comes from the sale of single use probes tied to the number of procedures performed. Additionally IceCure may place systems with customers who commit to purchasing a minimum volume of disposables over time.

IceCure operates in the competitive cryoablation and tumor ablation market alongside larger medical device firms such as Galil Medical a Boston Scientific subsidiary EndoCare a Siemens Healthineers subsidiary and Sanarus part of Hologic. The company differentiates itself through its liquid nitrogen based technology which achieves lower freezing temperatures than argon based systems leading to faster tumor destruction less patient pain reduced anesthesia needs and clearer intra procedural imaging. These technical advantages support IceCure's position as a niche innovator in minimally invasive cancer treatment.

IceCure's customers include hospitals ambulatory surgical centers private clinics and distributors that resell its products. In the United States the primary users are breast surgeons interventional radiologists and breast radiologists who perform cryoablation procedures. The company also works with distribution partners such as Terumo in Japan and Thailand and various regional distributors in Europe Asia and Latin America to reach end users.